COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics
The novel coronavirus disease 2019 (COVID-19) outbreak started in early December 2019 in the capital city of Wuhan, Hubei province, People's Republic of China, and caused a global pandemic. The number of patients confirmed to have this disease has exceeded 9 million in more than 215 countries,...
Main Author: | S.A. Azer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | New Microbes and New Infections |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2052297520300901 |
Similar Items
-
Editorial: Novel insights into the pathophysiology of diabetes-related complications: Implications for improved therapeutic strategies
by: Jian Ma, et al.
Published: (2023-03-01) -
Editorial: Novel insights into the pathophysiology of diabetes-related complications: implications for improved therapeutic strategies, volume II
by: Jian Ma, et al.
Published: (2025-02-01) -
Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment
by: Idris Zubairu Sadiq, et al.
Published: (2024-10-01) -
Vascular Pathophysiological Changes in Patients with COVID-19: A Review Article
by: Mohammad Hassani, et al.
Published: (2022-03-01) -
Pathophysiology, life style intervention and complications of Type-2 diabetes: A review
by: Mrinmoy Basak, et al.
Published: (2024-06-01)